Surveys Show: America’s Public Approval of Psychedelic Therapy Lags Behind Canada
Policy, ResearchWe compare two polls of roughly the same sample size in two neighboring countries, and find a stark difference in attitudes.
Australia’s First Psychedelic Research Institute Opens with $40 Million Investment
ResearchPsychae Institute will collaborate with other clinical research organizations to develop novel psychedelic medicines and accompanying psychotherapeutic treatment models.
How the Heroic Hearts Project Is Spearheading Psilocybin Research to Treat Veterans for TBI
ResearchDr. Grace Blest-Hopley tells Psychedelic Spotlight that the compound has anti-inflammatory effects on the brain, and explains how her team will investigate further through psilocybin retreats for veterans.
Oregon Psilocybin Advisory Board Finds the Psychedelic Reduces Depression and Anxiety
ResearchThe subcommittee’s review is the largest of its kind to be conducted in the state, which legalized psilocybin for therapeutic and medicinal purposes last November.
Ayahuasca May Help Curb Drug and Alcohol Addiction
ResearchNew study compiles the experiences of 8,629 ayahuasca users from 40 different countries, and results are very promising for the future of psychedelic-assisted therapy.
How a Psilocybin Study on AIDS Survivors Could Solve a Big Problem with Psychedelic Therapy
Research, TreatmentA group psilocybin study paves the way for increased scalability of novel treatments that typically require a lot of time for both the patient and therapist.
Wake Network Partners with Lieber Institute to Develop Genetics-Based Screening System for Psychedelic Therapies
Business, Research, TreatmentFungi bioscience company describes the project as “one of the most robust genetics research initiatives in the emerging psychedelics space to date."
How Wesana Health CEO Daniel Carcillo Plans to Protect Athletes From Traumatic Brain Injury
Research, TreatmentAnd why the two-time Stanley Cup champion does not imagine working with the NHL in the "near future."
COVID-19 Pandemic Study of Ketamine Therapy Amplifies Antidepressant Potential
Research, TreatmentStudy authors even believe "treating serious mental illness may reduce adverse outcomes related to COVID-19."
Awakn Life Sciences CEO Details ‘Groundbreaking’ MDMA Discovery in Quest to Treat Addiction
Business, Research, TreatmentAnthony Tennyson tells the Psychedelic Spotlight Podcast that his company has "discovered receptor sites that MDMA interacts with that we believe nobody else in the world knows about."